EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Atractylodes macrocephala in Ulcerative Colitis: Bioactive Constituents, Microbiota, and Translational Gaps

Shu-Huan Huang, Cheng-Chou Lai, Sum-Fu Chiang, Yi-Hong Wu, Jong-Hwei Su Pang

Pharmaceuticals · 12.11.2026 · 19 (11) · 1794

DOI: 10.3390/ph19111794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 12.11.2026. Verfasst von Shu-Huan Huang und 4 weiteren Autor:innen. Die Arbeit nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Memorial Hospital.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atractylodes macrocephala Koidz. rhizome (Atractylodis Macrocephalae Rhizoma, AMR; Bai-Zhu) is a widely used medicinal plant, and its specialized metabolites are now being mapped onto defined molecular targets. Existing reviews of this material are genus-wide, formula-level, or restricted to a single constituent class, and none grades the ulcerative-colitis (UC) evidence constituent by constituent while separating what has been demonstrated in colitis models from what is extrapolated from other disease contexts; that gap is the rationale for the present review. Here we review, constituent by constituent, how AMR acts in UC. The sesquiterpenoid lactones account for much of the activity: atractylenolide I protects the epithelial barrier (RhoA/ROCK/MLC; S100A9/AMPK/mTOR), reshapes intestinal metabolism and the microbiota (SPHK1/B4GALT2) and limits carbonic anhydrase IX-mediated ferroptosis, whereas atractylenolide II drives Nrf2-dependent antioxidant responses (in non-colitis models), and interleukin-17 receptor A is nominated as a candidate direct target of atractylenolide III—awaiting independent replication—through which it may curb macrophage M1 polarization. The polysaccharides rebalance Th17/Treg immunity and remodel the gut microbiota and its tryptophan metabolites with pregnane X receptor-associated signaling, while the volatile oil and vesicle-like particles are likewise protective. We grade each mechanism by the strength of the underlying colitis-model evidence and stay explicit about what remains extrapolation. Controlled human trials are still lacking, with only very preliminary clinical observation to date. Finally, we single out endothelial-leukocyte adhesion—already exploited by anti-adhesion biologics—as a promising but still untested hypothesis for translating these constituents toward the clinic.

Förderung

  • Chang Gung Memorial Hospital

Zitieren

APA

Huang, S., Lai, C., Chiang, S., Wu, Y., & Pang, J. S. (2026). Atractylodes macrocephala in Ulcerative Colitis: Bioactive Constituents, Microbiota, and Translational Gaps. Pharmaceuticals, 19(11), 1794. https://doi.org/10.3390/ph19111794

Vancouver

Huang S, Lai C, Chiang S, Wu Y, Pang JS. Atractylodes macrocephala in Ulcerative Colitis: Bioactive Constituents, Microbiota, and Translational Gaps. Pharmaceuticals. 2026;19(11):1794. doi:10.3390/ph19111794

BibTeX
@article{Huang2026,
  author = {Huang, Shu-Huan and Lai, Cheng-Chou and Chiang, Sum-Fu and Wu, Yi-Hong and Pang, Jong-Hwei Su},
  title = {Atractylodes macrocephala in Ulcerative Colitis: Bioactive Constituents, Microbiota, and Translational Gaps},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {11},
  pages = {1794},
  doi = {10.3390/ph19111794}
}
Kostenlos starten →